May 31, 2023

Press release - Non-regulatory

Circio invites to a company update on Thursday 15 June 2023

May 26, 2023

Press release - Regulatory

Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

May 25, 2023

Press release - Regulatory

Circio Holding ASA – New name registered

May 23, 2023

Press release - Regulatory

Circio Holding ASA: Requested Conversion of Convertible Bonds

May 22, 2023

Press release - Regulatory

Targovax ASA: Minutes from the Annual General Meeting

May 16, 2023

Press release - Non-regulatory

Circio: Link to recording and presentation from Company update 16[th] May 2023

May 12, 2023

Press release - Regulatory

Circio invites to a company update on Tuesday 16 May 2023

May 3, 2023

Press release - Regulatory

Targovax ASA – Correction of the proxy form attached to the notice of the Annual General Meeting

May 3, 2023

Press release - Non-regulatory

Circio: circRNA poster to be presented at the ASGCT Annual Meeting

April 28, 2023

Press release - Regulatory

Targovax ASA – Notice of Annual General Meeting

April 19, 2023

Press release - Regulatory

Targovax to rebrand as Circio, an innovator in next generation circular RNA therapeutics

April 13, 2023

Press release - Regulatory

Targovax ASA: Annual Report 2022

April 13, 2023

Press release - Non-regulatory

Targovax ASA: Registration of share capital increase following conversion of convertible bonds

April 13, 2023

Press release - Non-regulatory

Financial calendar

March 30, 2023

Press release - Non-regulatory

Targovax ASA: Requested Conversion of Convertible Bonds

March 15, 2023

Press release - Non-regulatory

Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting

March 14, 2023

Press release - Non-regulatory

Targovax: First patient dosed with TG01 in the USA

March 9, 2023

Press release - Regulatory

Targovax ASA – First Tranche of Convertible Bonds

March 9, 2023

Press release - Regulatory

Targovax ASA: Minutes from the Extraordinary General Meeting

March 7, 2023

Press release - Regulatory

Targovax to prioritize resources on unlocking the potential of its circRNA platform

March 6, 2023

Press release - Regulatory

Targovax ASA – Additional information prior to the Extraordinary General Meeting

March 6, 2023

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of restricted stock units

March 2, 2023

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs

March 2, 2023

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

March 1, 2023

Press release - Regulatory

Targovax ASA – Additional information prior to the Extraordinary General Meeting

February 23, 2023

Press release - Regulatory

Targovax invites to Q&A webcast regarding convertible bond financing

February 16, 2023

Press release - Regulatory

Targovax ASA – Notice of Extraordinary General Meeting

February 16, 2023

Press release - Regulatory

Targovax ASA: Fourth quarter 2022 results

February 16, 2023

Press release - Regulatory

Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform

February 8, 2023

Press release - Regulatory

Targovax ASA: Invitation to Targovax’s fourth quarter 2022 presentation, Thursday 16 February